<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="149727">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01983488</url>
  </required_header>
  <id_info>
    <org_study_id>LIGS10201</org_study_id>
    <nct_id>NCT01983488</nct_id>
  </id_info>
  <brief_title>Clinical Outcome in Uveitis</brief_title>
  <official_title>Clinical Outcome and Causes of Visual Loss in Uveitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moorfields Eye Hospital NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Moorfields Eye Hospital NHS Foundation Trust</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed at investigating the long term clinical outcome of patients with
      uveitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be included if they are treated for uveitis and have had repeat follow-up.
      Data will be gathered from the entire length of the patients follow-up.

      The main outcome measures will be:

      Change from baseline of Best corrected visual acuity (BCVA)at 10 years Causes of vision loss
      (≤6/15, VL) and severe vision loss (≤6/60, SVL) at 10 years Number of clinical visits at 10
      years.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>September 2011</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Best Corrected Visual Acuity</measure>
    <time_frame>up to 10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Recorded repeat best corrected visual acuity at intervals throughout the length of follow-up.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Causes of visual loss</measure>
    <time_frame>First follow-up, years 1,2,5,10, Final follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Record any ocular changes related to permanent visual loss under 6/12 and severe visual loss under 6/60.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Uveitis</condition>
  <arm_group>
    <arm_group_label>Uveitis</arm_group_label>
    <description>Patient with a clinical diagnosis of Uveitis.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patient data will be gathered from the uveitis clinic at Moorfields Eye Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical Diagnosis of Uveitis.

        Exclusion Criteria:

          -  No follow-up data.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sue Lightman, PhD,FRCOphth</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moorfields Eye Hospital NHS Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Moorfields Eye Hospital</name>
      <address>
        <city>London</city>
        <zip>EC1V 2PD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996 Apr;80(4):332-6.</citation>
    <PMID>8703885</PMID>
  </reference>
  <reference>
    <citation>Bodaghi B, Cassoux N, Wechsler B, Hannouche D, Fardeau C, Papo T, Huong DL, Piette JC, LeHoang P. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore). 2001 Jul;80(4):263-70. No abstract available.</citation>
    <PMID>11470987</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 13, 2013</lastchanged_date>
  <firstreceived_date>November 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Moorfields Eye Hospital NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Sue Lightman</investigator_full_name>
    <investigator_title>Professor of Clinical Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>Uveitis</keyword>
  <keyword>Vision Loss</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Uveitis</mesh_term>
    <mesh_term>Chorioretinitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
